Skip to content

Apotheek Bonte: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Bonte

BE 0804.144.351
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€6,654
2024 · €173,308-€166,654
Equity
€14,962
2024 · €8,308+€6,654
Cash
€119,227
2024 · €141,642-€22,416
Balance sheet total
€1.2m
2024 · €660,450+€576,185

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€337,162

    up €337,162 (+429%), from €78,646 to €415,809

    of which Other tangible fixed assets: +€252,855

  • Receivables within one year +€214,601

    up €214,601 (+84.0%), from €255,557 to €470,158

    of which Trade receivables: +€218,278

  • Stocks and contracts +€49,478

    up €49,478 (+28.4%), from €174,294 to €223,772

  • Cash -€22,416

    down €22,416 (-15.8%), from €141,642 to €119,227

    mainly Investment in fixed assets (net) (-€384,632) and Receivables within one year (-€214,601)

Equity and liabilities
  • Debts after one year +€349,225

    up €349,225 (+349%), from €100,000 to €449,225

    of which Financial debts: +€349,225

  • Other debts +€161,509

    up €161,509 (+66.7%), from €242,153 to €403,662

  • Trade debts +€29,422

    up €29,422 (+9.5%), from €309,989 to €339,411

  • Current portion of long-term debt +€27,204

    new in 2025: €27,204

Income statement
  • Gross operating margin -€180,688

    down €180,688 (-70.8%), from €255,305 to €74,617

  • Depreciation -€30,426

    down €30,426 (-39.1%), from €77,896 to €47,470

  • Financial charges +€12,659

    up €12,659 (+258%), from €4,912 to €17,571

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €173,308
Gross operating margin -€180,688
Depreciation +€30,426
Other operating charges -€202
Financial income -€1,361
Financial charges -€12,659
Taxes -€2,170
Result 2025 €6,654
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€14,213
Investment -€384,632
Financing +€376,430
Cash 2024 €141,642
Net result for the year +€6,654
Depreciation +€47,470
Stocks and contracts -€49,478
Receivables within one year -€214,601
Deferred charges and accrued income +€2,641
Trade debts +€29,422
Tax, wage and social debts +€2,170
Other debts +€161,509
Investment in fixed assets (net) -€384,632
Debts after one year +€349,225
Current portion of long-term debt +€27,204
Cash 2025 €119,227
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €660,450 €1,236,635 +€576,185 +87.2%
Fixed assets 21/28 €83,646 €420,809 +€337,162 +403%
Tangible fixed assets 22/27 €78,646 €415,809 +€337,162 +429%
Plant, machinery and equipment 23 €16,549 €101,469 +€84,920 +513%
Furniture and vehicles 24 €7,657 €7,045 -€612 -8.0%
Other tangible fixed assets 26 €54,439 €307,294 +€252,855 +464%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €576,804 €815,826 +€239,023 +41.4%
Stocks and contracts in progress 3 €174,294 €223,772 +€49,478 +28.4%
Stocks 30/36 €174,294 €223,772 +€49,478 +28.4%
Amounts receivable within one year 40/41 €255,557 €470,158 +€214,601 +84.0%
Trade receivables 40 €219,406 €437,684 +€218,278 +99.5%
Other amounts receivable 41 €36,151 €32,475 -€3,676 -10.2%
Cash at bank and in hand 54/58 €141,642 €119,227 -€22,416 -15.8%
Deferred charges and accrued income 490/1 €5,310 €2,669 -€2,641 -49.7%
Total equity and liabilities 10/49 €660,450 €1,236,635 +€576,185 +87.2%
Equity 10/15 €8,308 €14,962 +€6,654 +80.1%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €3,308 €9,962 +€6,654 +201%
Distributable reserves 133 €3,308 €9,962 +€6,654 +201%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €652,142 €1,221,673 +€569,531 +87.3%
Amounts payable after more than one year 17 €100,000 €449,225 +€349,225 +349%
Financial debts 170/4 - €349,225 +€349,225
Other amounts payable 178/9 €100,000 €100,000 = 0.0%
Amounts payable within one year 42/48 €552,142 €772,448 +€220,306 +39.9%
Current portion of amounts payable after more than one year 42 - €27,204 +€27,204
Trade debts 44 €309,989 €339,411 +€29,422 +9.5%
Suppliers 440/4 €309,989 €339,411 +€29,422 +9.5%
Taxes, remuneration and social security 45 - €2,170 +€2,170
Taxes 450/3 - €2,170 +€2,170
Other amounts payable 47/48 €242,153 €403,662 +€161,509 +66.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €77,896 €47,470 -€30,426 -39.1%
Other operating charges 640/8 €1,123 €1,326 +€202 +18.0%
Gross operating margin 9900 €255,305 €74,617 -€180,688 -70.8%
Operating profit (loss) 9901 €176,286 €25,822 -€150,464 -85.4%
Financial income 75/76B €1,934 €573 -€1,361 -70.4%
Recurring financial income 75 €1,934 €573 -€1,361 -70.4%
Financial charges 65/66B €4,912 €17,571 +€12,659 +258%
Recurring financial charges 65 €4,912 €17,571 +€12,659 +258%
Profit (loss) for the period before taxes 9903 €173,308 €8,824 -€164,484 -94.9%
Income taxes 67/77 - €2,170 +€2,170
Profit (loss) for the period 9904 €173,308 €6,654 -€166,654 -96.2%
Profit (loss) for the period to be appropriated 9905 €173,308 €6,654 -€166,654 -96.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.